EUVIMEDEUVIMED entdecken
Crossref

Cost‐effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence

Fumiaki Ishibashi iD, Sho Suzuki iD, Konomi Kobayashi, Ryu Tanaka, Tomohiro Kawakami, Kentaro Mochida, Mizuki Nagai, Yuichi Ishibashi, Tetsuo Morishita

Journal of Gastroenterology and Hepatology · 2024-11 · 39 (11) · 2424-2431

DOI: 10.1111/jgh.16715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 09.08.2024. Verfasst von Fumiaki Ishibashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, International University of Health and Welfare Ichikawa Hospital, Ichikawa, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Cost-Benefit Analysis, Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Periodic endoscopic screening for gastric cancer (GC) is widely performed in East Asia; however, the optimal screening strategy remains unclear. This study aimed to determine the most cost‐effective endoscopic screening strategy for the detection and treatment of GC in a cohort with a low Helicobacter pylori prevalence.

Methods

The following data were retrospectively extracted from participants who received screening endoscopy between April 2019 and March 2023: age, H. pylori infection status, presence of intestinal metaplasia, pathological diagnosis of GC, and the interval between the most recent endoscopies. A Markov state transition model was constructed based on the cohort data. The cost‐effectiveness of 15 strategies with different starting ages (40/50/60 years) and screening intervals (1/2/3/4/5 years) was compared. The net monetary benefit (NMB) and incremental cost‐effectiveness ratio (ICER) of quality‐adjusted life‐years gained by treatment were used as outcomes.

Results

A simulation model was constructed based on the cohort data of 94 137 participants (mean age 54.5 years, males 57.9%; 74.4% H. pylori ‐naïve, 94.2% intestinal metaplasia‐negative). The results of the base‐case analysis showed that the screening strategy of 4‐year intervals starting at the age of 40 years had the highest NMB (97 401 578 yen). In both the Monte Carlo simulation and one‐way sensitivity analysis with a varying probability of H. pylori infection status transition, the ICER was superior in the screening strategy every 4 years, starting at age 40 years.

Conclusions

Our simulation showed that endoscopic screening at 4‐year intervals starting at the age of 40 years was the most cost‐effective method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsCost-Benefit AnalysisHelicobacter InfectionsHelicobacter pyloriEarly Detection of CancerHumansMaleMiddle AgedFemalePrevalenceAdultRetrospective StudiesCohort StudiesQuality-Adjusted Life YearsGastroscopyMarkov ChainsMass ScreeningAged

Stichwörter der Autor:innen

H. pyloricost‐effectiveness analysisendoscopygastric cancerscreening

Autor:innen und Institutionen

  • Department of Gastroenterology, International University of Health and Welfare Ichikawa Hospital, Ichikawa, Japan.
  • Endoscopy Center, Koganei Tsurukame Clinic, Tokyo, Japan.
  • Digestive Disease Center, Shinjuku Tsurukame Clinic, Tokyo, Japan.
  • Research and Development Initiative, Chuo University, Tokyo, Japan.

ORCID-Profile: Fumiaki Ishibashi, Sho Suzuki

Zitieren

APA

Ishibashi, F., Suzuki, S., Kobayashi, K., Tanaka, R., Kawakami, T., Mochida, K., Nagai, M., Ishibashi, Y., & Morishita, T. (2024). Cost‐effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence. Journal of Gastroenterology and Hepatology, 39(11), 2424-2431. https://doi.org/10.1111/jgh.16715

Vancouver

Ishibashi F, Suzuki S, Kobayashi K, Tanaka R, Kawakami T, Mochida K, et al. Cost‐effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence. Journal of Gastroenterology and Hepatology. 2024;39(11):2424-2431. doi:10.1111/jgh.16715

BibTeX
@article{Ishibashi2024,
  author = {Ishibashi, Fumiaki and Suzuki, Sho and Kobayashi, Konomi and Tanaka, Ryu and Kawakami, Tomohiro and Mochida, Kentaro and Nagai, Mizuki and Ishibashi, Yuichi and Morishita, Tetsuo},
  title = {Cost‐effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  volume = {39},
  number = {11},
  pages = {2424--2431},
  doi = {10.1111/jgh.16715}
}
Kostenlos starten →